Bacterial cyclic dinucleotides are recognized by the innate immune system, and this leads to the induction of type I interferons. The mammalian helicase DDX41 directly binds cyclic dinucleotides and mediates the signaling pathway to the induction of type I interferons.
such upregulation to inhibit and consequently to escape Ly49A + NK cells. In this context, it may be noteworthy that Ly49A is polymor phic. Distinct alleles encoding Ly49A produce molecules that vary in their affinity for H2D d and may thus also differ in their affinity for the monomorphic H2M3 molecule. Thus, the extent of H2M3dependent inhibition of an NK cell response may vary in different mouse strains. Finally, the presence or absence of a strong classical MHC class I ligand for Ly49A represents yet another variable that may influ ence the contribution of H2M3 to the regu lation of NK cell function. Given all of these considerations, it will be of interest to deter mine whether it is the host or the bacteria that profits from the H2M3-Ly49A interaction and whether the result is the same in different strains of mice.
In summary, Smyth and colleagues find that the nonclassical MHC class I molecule H2M3 binds Ly49A but not other recep tors of the Ly49 family. This interaction improves the responsiveness of Ly49A + NK cells and allows these cells to react to nor mal bone marrow cells that lack H2M3 and to protect from B16 lung metastasis. These findings will undoubtedly trigger renewed interest in the possible recognition of other nonclassical MHC class I molecules by NK cells and the roles of such interactions in cancer and infection.
T he detection of viral and bacterial nucleic acids by the innate immune system, which leads to the induction of type I interferons (IFNα and IFNβ), is now an area of intense research. The interest is not only in determin ing the mechanisms whereby pathogens are sensed but also in understanding how inap propriate activation of such mechanisms by self nucleic acids can lead to autoimmunity. Host patternrecognition receptors (PRRs) that detect pathogen RNA and DNA on the cell surface, in endosomes and within the cytosol and nucleus have been proposed and identified and, in some cases (such as the Tolllike receptors) characterized extensively. However, it has become apparent that small bacterial nucleic acids called 'cyclic dinucleo tides' (CDNs) are also able to elicit an innate immune response when present in the cytosol. In a study published in this issue of Nature Immunology, Parvatiyar et al. show that the cellular DEAD (aspartateglutamatealanine aspartate)box helicase DDX41 binds bacterial CDNs and is responsible for activating the sig naling pathway that leads to the induction of type I interferons 1 .
Bacterial CDNs such as cyclic diAMP and cyclic diGMP are second messengers with a regulatory role in normal bacterial physio logy. For example, cyclic diGMP regulates the motility and expression of genes encoding molecules associated with virulence 2 . Such CDNs are not thought to be produced by mammalian cells and should appear in the cytosol only because of the presence of invading bacteria. Thus, they are candidate 'vita-pathogenassociated molecular pat terns' , whose recognition signals the presence of live microbes to the innate immune system 3 . Indeed, CDNs from intracellular bacteria such as Listeria and Pseudomonas species stimu late an innate immune response particularly characterized by the induction of type I inter ferons and do so via the cytosolic signaling axis composed of the adaptor STING, the kinase TBK1 and the transcription factor IRF3, an axis also used for the sensing of cytosolic DNA by the innate immune system [4] [5] [6] . Parvatiyar et al. now demonstrate that the helicase DDX41 operates 'upstream' of STINGTBK1IRF3 to sense CDNs and trigger the STINGdependent pathway 1 (Fig. 1) .
Very little was known about the function of DDX41 until it was shown to sense cytosolic doublestranded DNA (dsDNA), such as that from DNA viruses, which leads to activation of the STINGTBKIRF3 pathway 7 . At that time, DDX41 joined a growing list of helicases linked to the sensing of RNA (such as RIGI, Mda5 and DDX60) and DNA (such as DHX36 and DHX9) by the innate immune system 8 . However, the article by Parvatiyar et al. is the first demonstration of a role for a helicase in detecting CDNs 1 . Such a role is demonstrated by the finding that knockdown of DDX41 expression through the use of short hairpin RNA (shRNA) in both mouse and human cell lines blocks CDNstimulated induction of the gene encoding IFNβ and other genes of the innate immune system, such as the gene encoding tumornecrosis factor. Furthermore, knockdown of DDX41 also inhibits CDN and Listeria bacteria-dependent induction of genes in primary mouse bone marrowderived dendritic cells, mouse peritoneal macrophages and human peripheral blood mononuclear cells. Given that nucleic acidsensing pathways are often celltype specific, it is compelling that DDX41 is required for responses to CDN in such a range of human and mouse cells.
volume 13 number 12 DeCember 2012 nature immunology is required for the recruitment of TBK1 to STING and downstream signaling (Fig. 1) . Published work using in vitro reconstitution of the STINGTBK1IRF3 axis has shown that the carboxyterminal tail of STING acts as a scaffold that binds both TBK1 and IRF3 to direct TBK1 to phosphorylate and activate IRF3 (ref. 11). Therefore, the engagement of CDNs with DDX41 and STING would be expected to trigger the movement of STING to perinuclear structures and also to cause a conformational change in STING, which would expose the carboxyterminal tail to allow the recruitment of TBK1. However, such a mechanism has not yet been clari fied, although Parvatiyar et al. do show that CDNs stimulate the recruitment of TBK1 to a STINGcontaining complex in cells 1 .
In a wider context, the exact mechanism whereby DEADbox proteins function as cyto solic PRRs for nucleic acids remains a fascinat ing enigma. Unlike other PRRs, such as Tolllike receptors and RIGIlike receptors, DDX41
does not yet have a clearly defined signaling domain that is distinct from its nucleic acidbinding domain, which makes it difficult to explain how the binding of dsDNA 7 or CDNs 1 to the DEAD domain would trigger the recruit ment of signaling adaptors (or STING directly) and hence stimulate downstream signaling. The DEAD domain itself has been shown to be required for the binding of DDX41 to STING after stimulation with dsDNA 7 , so this may also be the case for the CDN pathway. This raises the possibility that other DEADbox proteins might also sense CDNs and act via STING, possibly in different cell types, as the DEAD domain is well conserved in the DDX protein family.
Further structural studies will be needed to elucidate how DDX41 engages DNA and CDNs and whether the interaction with STING is direct or other signaling proteins are involved. It will be of particular interest to assess DDX41deficient mice to determine whether DDX41 is essential or redundant with other sensors of nucleic acid in mice in vivo, notwithstanding the likelihood that nucleic acid-sensing pathways in mice and humans are probably distinct. Given its role in DNA sens ing, it might be expected that similar to other nucleic acid PRRs, DDX41 may have a role in mediating autoimmunity in certain contexts. Finally, CDNs, acting via DDX41 and STING, may prove to be useful vaccine adjuvants. Thus, there will probably be continued intense inter est in elucidating the relative roles of DDX41 and STING, and their exact mechanisms of action, in the sensing of nucleic acids.
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(normally RNA or DNA) and hydrolyzing ATP 9 . Here, the binding of CDNs by DDX41 is shown to require the DEAD domain but not the helicase domain 1 Published studies have suggested that STING itself is the cytosolic receptor for CDNs. Thus, the idea was that in contrast to dsDNA, CDNs do not require a further 'upstream' sensor to activate the STINGTBK1IRF3 axis 5 . Several papers have described the structure of one molecule of cyclic diGMP bound to a dimer of the carboxyterminal domain of human STING 10 . To compare the relative impor tance of DDX41 and STING in the sensing of CDNs, Parvatiyar et al. compare the affinities of cyclic diGMP and cyclic diAMP for both proteins 1 . Data obtained with cell lysates, intact cells and in vitro binding assays with recom binant proteins all suggest that DDX41 has a greater affinity for CDNs than does STING. Furthermore, DDX41specific shRNA con siderably inhibits the ability of STING in cell lysates to associate with cyclic diGMP and the localization of STING together with cyclic diGMP in intact cells. In contrast, lowering the expression of STING does not affect the localization of DDX41 together with cyclic diGMP. Thus, the authors propose DDX41 as the main sensor of CDNs and also propose that DDX41 is required for STING to bind CDNs in intact cells. This would suggest that STING might be a secondary receptor or cofac tor for CDN sensing. It is also possible that the DDX41 pathway may require that CDNs bind to STING for full activation of the DDX41 dependent response to CDNs.
This work raises other interesting questions related to the mechanism whereby CDNs activate the STINGTBK1IRF3 axis, as it remains unclear how CDNs, either bound to DDX41 or directly to STING, stimulate STING to activate TBK1. One hallmark of the activa tion of STING after stimulation with dsDNA or CDNs is its movement from the endoplas mic reticulum and possibly the mitochondria to perinuclear punctate structures that remain not well defined. Such movement of STING Parvatiyar et al. also provide evidence that, as with its binding to dsDNA 7 , DDX41 can also directly bind to CDNs: CDNs precipi tate DDX41 from cell lysates and also local ize together with DDX41 in intact cells 1 . Notably, they find that recombinant DDX41 protein directly binds both cyclic diGMP and cyclic diAMP, but not to structurally similar molecules, in vitro. DEADbox helicases such as DDX41 have two conserved domains-a DEAD domain and a helicase domain-and both domains act together to fulfill the key functions of helicases in binding nucleic acid Figure 1 A mechanism whereby DDX41 senses bacterial CDNs and dsDNA to mediate the induction of type I interferons. The presence of dsDNA and the CDNs cyclic di-GMP and cyclic di-AMP signal the presence of invading bacteria to the cellular innate immune system. These nucleic acids are sensed by DDX41 through binding of the dsDNA or CDNs to the central DEAD-box domain (DEADc). The binding of ligand to DDX41 then causes the association of DDX41 with a sTING dimer at the endoplasmic reticulum (ER) and subsequent movement of sTING to perinuclear punctate structures via a mechanism that remains poorly defined. such movement of sTING is necessary for the recruitment and activation of TBK1 to phosphorylate IRF3, which causes dimerization of that transcription factor and induction of type I interferons (IFNs). HelicC, carboxyterminal helicase domain. 
he NFκB family of transcription factors acts prominently in both the development and function of the immune system and, con sequently, in diseases of dysregulated immune responses and cell proliferation. The broad scope of NFκB biology has made it difficult to target NFκB therapeutically without first identifying the functions or regulatory mecha nisms that act selectively in specific biological processes. The need to understand the complex regulatory mechanisms that govern NFκB signaling has spurred continuing efforts to generate mathematical models of the NFκB pathway. These models have focused mainly on recapitulating and probing the dynamics and regulation of the activation of NFκB in spe cific signaling pathways. In this issue of Nature Immunology, Shih et al. have instead applied mathematical modeling to identify a cell typespecific NFκB pathway and elucidate how this pathway is organized and regulated 1 . The authors use an iterative process of careful bio chemical observation and refinement of their mathematical models to arrive at a surprisingly small number of variables that enforce strik ing differences between dendritic cell (DC) and macrophage NFκB signaling pathways. In the process, they demonstrate the efficacy of com bining computational modeling with biochem istry to analyze signaling mechanisms-in this case, in the NFκB pathway.
Shih et al. start from a model they have developed over the course of several years that recapitulates many of the measurable signal ing events that follow the stimulation of mouse embryonic fibrobasts (MEFs) 1, 2 . However, this model had not yet been applied to cells of the immune system. DC maturation is essential to initiation of most adaptive immune responses, and it is well known that NFκB has an impor tant role in DC maturation. To adapt this model to DCs, the authors measure baseline expression of components of the NFκB path way. In doing so, they find that the NFκB pro tein RelB, long known to be important for DC development 3 , has higher expression in DCs than in macrophages or MEFs. When Shih et al. adjust their parameters to account for a greater abundance of RelB and other observed changes in components of the NFκB path way, they predict, based on the model, that most RelB would be active (nuclear) in resting DCs. This is because there is an insufficient concentration of the RelB inhibitor p100. Surprisingly, they instead find that most RelB is cytoplasmic, which suggests that it is being inhibited through another mechanism. Indeed, they find a substantial portion of RelB is bound together with p50 and exists in a complex with the NFκB inhibitors IκBα or IκBε.
The five members of the NFκB familyp65 (RelA), RelB, p50, p52 and cRel-exist as dimers whose ability to translocate to the nucleus, bind DNA and transactivate gene expression is regulated through bind ing to one of the seven members of the IκB family 3 . Only a few of the many potential NFκB-IκB complexes have been found in cells and, of these, the bulk of the litera ture has focused mainly on three: p65p50 and cRel-p50, which are regulated by IκBα and activated by the canonical pathway, and RelBp52, which is activated by the alterna tive, or noncanonical, NFκB pathway (Fig. 1) . The canonical pathway requires NEMO, a noncatalytic regulatory component of the IκB kinase (IKK) complex, and proceeds through the phosphorylation, ubiquitination and degradation of one of the following three IκB proteins: IκBα, IκBβ or IκBε (Fig. 1) . The noncanonical pathway is dependent on IKKα and independent of NEMO and involves the phosphorylation and ubiquitination of p100 and proteasomal processing of p100 to p52 (ref. 4) . The noncanonical pathway is subject to active repression by ubi quitination depen dent on the ubiquitin ligase TRAF3 and proteasomal degradation of the kinase NIK. Thus, noncanonical signaling is initiated after degradation of TRAF3 and accumula tion of NIK, which activates IKKα, leading to the phosphorylation of p100; this ultimately results in the production of RelBp52 dimers. An unintentional consequence of the clear delineation of these two signaling pathways has been tacit acceptance of the idea that RelB is regulated solely through the nonca nonical pathway. Although many exceptions have been observed, this model has neverthe less 'proliferated' .
The finding of RelBp50 in the cytoplasm bound to IκBα or IκBε is surprising and indicates that these RelB complexes would be subject to regulation by stimuli of the canoni cal pathway, which directly contradicts the idea that RelB is regulated only by the non canonical pathway. Shih et al. indeed show that these RelBp50 dimers are regulated by canonical stimuli and contribute to NFκB dependent gene expression and DC matura tion 1 . Published reports have shown that RelB in DCs translocates to the nucleus in response to stimuli of the canonical pathway and have suggested that the RelB involved might be part of a RelBp50 dimer 5 . However, those atypical RelBcontaining complexes were never fully established, as it was not previously demon strated that they make a relevant contribution to NFκB activation. Furthermore, because of the weak and delayed appearance of RelB complexes in earlier reports, it was not clear that they were direct targets of canonical signaling. In fact, other studies have shown upregulation of RelB after activation of canonical NFκB 6, 7 and that the induced RelB can bind p50 (refs. 6,8) , which would suggest the possibility of an indi rect mechanism. However, Shih et al. establish
